Lensar (LNSR) EBITDA Margin Growth (1y) (2020 - 2026)
Lensar (LNSR) EBITDA Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.08 Bn | 175.79 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 128.71 Bn | 125.83 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 108.79 Bn | 99.57 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 68.41 Bn | 66.96 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn | 102.00 |
| 6 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | -313.00 |
| 7 | Dexcom | 28.34 Bn | 27.22 Bn | 750.30 Mn | 851.00 |
| 8 | Smith & Nephew | 26.87 Bn | 26.29 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 241.00 |
| 10 | Lensar | 66.89 Mn | 55.79 Mn | 6.38 Mn | 5,757.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,757.00 |
| Dec 31, 2025 | -3,918.00 |
| Sep 30, 2025 | -4,889.00 |
| Jun 30, 2025 | -175.00 |
| Mar 31, 2025 | 94,187.00 |
| Dec 31, 2024 | 1,417.00 |
| Sep 30, 2024 | 1,413.00 |
| Jun 30, 2024 | -2,164.00 |
| Mar 31, 2024 | -92,991.00 |
| Dec 31, 2023 | 218.00 |
| Sep 30, 2023 | 2,803.00 |
| Jun 30, 2023 | 7,486.00 |
| Mar 31, 2023 | 1,870.00 |
| Dec 31, 2022 | 449.00 |
| Sep 30, 2022 | 3,554.00 |
| Jun 30, 2022 | -3,813.00 |
| Mar 31, 2022 | 1,611.00 |
| Dec 31, 2021 | 11,137.00 |
| Sep 30, 2021 | -1,063.00 |
| Jun 30, 2021 | 1,945.00 |